<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>CagriSema: what changed | Grey Peptides</title>
    <link>https://greypeptides.com/changes/#e-cagrisema</link>
    <atom:link href="https://greypeptides.com/changes/cagrisema.xml" rel="self" type="application/rss+xml" />
    <description>News, regulatory alerts, corrections and new guides about CagriSema on Grey Peptides, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 28 Oct 2026 12:00:00 +0000</lastBuildDate>
    <ttl>1440</ttl>
    <item>
      <title>Correction: Corrected: CagriSema</title>
      <link>https://greypeptides.com/corrections/#c-q924-cagrisema-redefine2</link>
      <guid isPermaLink="false">greypeptides-changes-cagrisema-corr-c-q924-cagrisema-redefine2</guid>
      <pubDate>Wed, 28 Oct 2026 12:00:00 +0000</pubDate>
      <category>Correction</category>
      <description>REDEFINE 2 gave 13.7% weight loss at 68 weeks against 3.4% on placebo (treatment-policy estimand).</description>
    </item>
    <item>
      <title>News: CagriSema Against Tirzepatide in Type 2 Diabetes: What REIMAGINE 5 Shows</title>
      <link>https://greypeptides.com/news/reimagine-5-cagrisema-vs-tirzepatide/</link>
      <guid isPermaLink="false">greypeptides-changes-cagrisema-news-reimagine-5-cagrisema-vs-tirzepatide</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 +0000</pubDate>
      <category>News</category>
      <description>CagriSema Against Tirzepatide in Type 2 Diabetes: What REIMAGINE 5 Shows</description>
    </item>
    <item>
      <title>News: CagriSema's Diabetes Trials Read Out: What REIMAGINE 1, 2 and 3 Found</title>
      <link>https://greypeptides.com/news/reimagine-cagrisema-type2-diabetes/</link>
      <guid isPermaLink="false">greypeptides-changes-cagrisema-news-reimagine-cagrisema-type2-diabetes</guid>
      <pubDate>Wed, 30 Sep 2026 12:00:00 +0000</pubDate>
      <category>News</category>
      <description>CagriSema's Diabetes Trials Read Out: What REIMAGINE 1, 2 and 3 Found</description>
    </item>
    <item>
      <title>News: ADA 2026 Preview: The Incretin Readouts to Watch in New Orleans</title>
      <link>https://greypeptides.com/news/ada-2026-scientific-sessions-preview/</link>
      <guid isPermaLink="false">greypeptides-changes-cagrisema-news-ada-2026-scientific-sessions-preview</guid>
      <pubDate>Thu, 04 Jun 2026 12:00:00 +0000</pubDate>
      <category>News</category>
      <description>ADA 2026 Preview: The Incretin Readouts to Watch in New Orleans</description>
    </item>
    <item>
      <title>News: REDEFINE-1 Body Composition Data: How CagriSema Affects Muscle Mass</title>
      <link>https://greypeptides.com/news/cagrisema-redefine-1-body-composition-eco2026/</link>
      <guid isPermaLink="false">greypeptides-changes-cagrisema-news-cagrisema-redefine-1-body-composition-eco2026</guid>
      <pubDate>Tue, 12 May 2026 12:00:00 +0000</pubDate>
      <category>News</category>
      <description>REDEFINE-1 Body Composition Data: How CagriSema Affects Muscle Mass</description>
    </item>
  </channel>
</rss>
